Pharmaceuticals 2009, 2(3), 206-216; doi:10.3390/ph2030206
Review

Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon

Robert M. Friedman* email and Sara Contenteemail
Department of Pathology, F. Edward Hébert School of Medicine, USUHS/4301 Jones Bridge Rd, Bethesda, MD 20814, USA
* Author to whom correspondence should be addressed.
Received: 13 November 2009; in revised form: 2 December 2009 / Accepted: 7 December 2009 / Published: 15 December 2009
(This article belongs to the Special Issue Interferons)
PDF Full-text Download PDF Full-Text [164 KB, uploaded 15 December 2009 10:36 CET]
Abstract: For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.
Keywords: interferon; clinical applications; cancer; infectious diseases; multiple sclerosis

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Friedman, R.M.; Contente, S. Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon. Pharmaceuticals 2009, 2, 206-216.

AMA Style

Friedman RM, Contente S. Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon. Pharmaceuticals. 2009; 2(3):206-216.

Chicago/Turabian Style

Friedman, Robert M.; Contente, Sara. 2009. "Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon." Pharmaceuticals 2, no. 3: 206-216.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert